thumbnail image
  • About Us
  • Products
  • OEM Service
  • …  
    • About Us
    • Products
    • OEM Service
    • About Us
    • Products
    • OEM Service
    • …  
      • About Us
      • Products
      • OEM Service
      Go Back
      NUPhadex G-10M, 15M & 50M Size Exclusion Resin

      NUPhadex G-10M, 15M & 50M Size Exclusion Resin

      The NUPhadex G-10 M, NUPhadex G-15 M, and NUPhadex G-50 M series size exclusion resins are epichlorohydrin-crosslinked dextran microspheres. The dry powder particle sizes of these three products are similar. After swelling, the microspheres are rigid, with decreasing crosslinking density, increasing swelling factor for the dry powder, and increasing globular protein exclusion limits in the order G-10 M < G-15 M < G-50 M.
      Dextran exhibits extremely low non-specific adsorption to biomolecules. These hydrophilic, porous crosslinked dextran microspheres are primarily used for rapid buffer exchange and desalting of biomolecules in group separation processes, featuring minimal sample dilution, high desalting efficiency, and high recovery. Relatively large biomolecules have short retention times in the resin, while salts and other small molecules in the buffer are retained longer. Molecules of different sizes are separated based on their differing residence times in the resin, making this product series suitable for various biomolecular samples such as proteins, polysaccharides, and nucleic acids.
      More Details

      NUPhadex G-10M, 15M & 50M Size Exclusion Resin

      • background image
      Section image

      Location:

      Room 803, No. 10 Lane 10, Gankeng New Village, Gankeng Community, Jihua Street, Longgang District, ShenZhen, China

      Docs

      Catalogues

      Technical Datasheet

      MSDS

      COA

      Contact Us

      Phone: +86 13169519515

      Email: mikka.lv@dotwaybio.com

      Monday-Friday: 8:00-18:00

      © Dotway (ShenZhen) Biotech Co.,Ltd

        Cookie Use
        We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
        Learn More